Loomis, Sayles & Company’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-527,228
| Closed | -$9.24M | – | 873 |
|
|
2018
Q1 | $9.24M | Sell |
527,228
-18,650
| -3% | -$327K | 0.02% | 442 |
|
|
2017
Q4 | $13.5M | Sell |
545,878
-4,998
| -0.9% | -$123K | 0.03% | 364 |
|
|
2017
Q3 | $14.2M | Buy |
550,876
+73,259
| +15% | +$1.89M | 0.03% | 349 |
|
|
2017
Q2 | $13M | Buy |
477,617
+77,654
| +19% | +$2.11M | 0.03% | 362 |
|
|
2017
Q1 | $11.9M | Buy |
+399,963
| New | +$11.9M | 0.03% | 386 |
|